Literature DB >> 16025768

Musculoskeletal and neuromuscular interventions: a physical approach to cystic fibrosis.

Mary Massery1.   

Abstract

Children with CF are living longer than ever before, and thus issues pertaining to quality of life rather than just longevity of life need to be addressed by the entire healthcare team. This article addressed the issues pertaining to the external support of the dysfunctional internal organs: the secondary musculoskeletal (postural) and neuromuscular control deficits that occur to the maturing child with CF. The research pointed towards starting PT interventions for these deficits during the pre-pubescent phase when postural deficits were just emerging, but a suggestion was also made to explore whether these deficits can be even more effectively monitored and treated at an earlier age. The dual relationship between the muscles used to meet the increased respiratory demands of CF and the normal postural demands of physical activities was described through a model based on a soda-pop can and pressure support. A pre-pubescent child with a typical progression of CF was presented as a case report to illustrate how a PT programme that was focused on postural deficits could be implemented and what type of outcomes might be possible. The child made significant changes within a relatively short time frame of 4 months, proposing that the musculoskeletal and neuromuscular systems may play a significant role in the medical and physical long-term outcomes of CF. For that reason, the physical as well as medical needs of the patient should be incorporated into a comprehensive multi-system approach to the disease across the lifespan.

Entities:  

Mesh:

Year:  2005        PMID: 16025768      PMCID: PMC1308809     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  40 in total

1.  Complications during the acute phase of traumatic spinal cord lesions.

Authors:  S Aito
Journal:  Spinal Cord       Date:  2003-11       Impact factor: 2.772

2.  Intervertebral stiffness of the spine is increased by evoked contraction of transversus abdominis and the diaphragm: in vivo porcine studies.

Authors:  Paul Hodges; Allison Kaigle Holm; Sten Holm; Lars Ekström; Andrew Cresswell; Tommy Hansson; Alf Thorstensson
Journal:  Spine (Phila Pa 1976)       Date:  2003-12-01       Impact factor: 3.468

3.  Experimental muscle pain changes feedforward postural responses of the trunk muscles.

Authors:  Paul W Hodges; G Lorimer Moseley; Anna Gabrielsson; Simon C Gandevia
Journal:  Exp Brain Res       Date:  2003-06-03       Impact factor: 1.972

4.  Spinal stiffness changes throughout the respiratory cycle.

Authors:  D Shirley; P W Hodges; A E M Eriksson; S C Gandevia
Journal:  J Appl Physiol (1985)       Date:  2003-10

5.  Pain differs from non-painful attention-demanding or stressful tasks in its effect on postural control patterns of trunk muscles.

Authors:  G Lorimer Moseley; M K Nicholas; Paul W Hodges
Journal:  Exp Brain Res       Date:  2003-12-19       Impact factor: 1.972

6.  Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis.

Authors:  Alina A Ionescu; William D Evans; Rebecca J Pettit; Lisette S Nixon; Michael D Stone; Dennis J Shale
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

7.  Chest physiotherapy, gastro-oesophageal reflux, and arousal in infants with cystic fibrosis.

Authors:  B M Button; R G Heine; A G Catto-Smith; P D Phelan; A Olinsky
Journal:  Arch Dis Child       Date:  2004-05       Impact factor: 3.791

Review 8.  Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.

Authors:  Oscar Gluck; Gene Colice
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

9.  Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.

Authors:  H M Buntain; R M Greer; P J Schluter; J C H Wong; J A Batch; J M Potter; P J Lewindon; E Powell; C E Wainwright; S C Bell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 10.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  8 in total

1.  THE LINDA CRANE MEMORIAL LECTURE: The Patient Puzzle: Piecing it Together.

Authors:  Mary Massery
Journal:  Cardiopulm Phys Ther J       Date:  2009-06

2.  The reliability and validity of the Saliba Postural Classification System.

Authors:  Cristiana Kahl Collins; Vicky Saliba Johnson; Ellen M Godwin; Evangelos Pappas
Journal:  J Man Manip Ther       Date:  2016-07

3.  Chronic Pain in People With Chronic Obstructive Pulmonary Disease: Prevalence, Clinical and Psychological Implications.

Authors:  Annemarie L Lee; Roger S Goldstein; Dina Brooks
Journal:  Chronic Obstr Pulm Dis       Date:  2017-05-21

4.  Muscle length and joint range of motion in children with cystic fibrosis compared to children developing typically.

Authors:  Allison Mandrusiak; Donnae Giraud; Julie MacDonald; Christine Wilson; Pauline Watter
Journal:  Physiother Can       Date:  2010-04-23       Impact factor: 1.037

5.  Respiratory functional and motor control deficits in children with spinal cord injury.

Authors:  Goutam Singh; Andrea L Behrman; Sevda C Aslan; Shelley Trimble; Alexander V Ovechkin
Journal:  Respir Physiol Neurobiol       Date:  2017-10-28       Impact factor: 1.931

6.  Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults.

Authors:  Tracey Daniels
Journal:  J Multidiscip Healthc       Date:  2010-11-19

7.  Pain is a common problem in patients with ILD.

Authors:  Qinxue Shen; Ting Guo; Min Song; Wei Guo; Yi Zhang; Wang Duan; Yating Peng; Shanshan Ni; Xiaoli Ouyang; Hong Peng
Journal:  Respir Res       Date:  2020-11-11

8.  Thoracic Kyphosis is Now Uncommon Amongst Children and Adolescents with Cystic Fibrosis.

Authors:  Nicki Barker; Ashok Raghavan; Pauline Buttling; Kostas Douros; Mark Lloyd Everard
Journal:  Front Pediatr       Date:  2014-02-17       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.